Related by context. All words. (Click for frequent words.) 75 GERD symptoms 73 OAB symptoms 71 IBS symptoms 71 nighttime awakenings 70 PMS symptoms 70 urinary symptoms 70 ADHD symptoms 69 vasomotor symptoms 68 depressive symptoms 68 symptom severity 68 BPH symptoms 68 pramipexole 68 reflux symptoms 67 daytime sleepiness 67 overactive bladder symptoms 67 nocturia 67 gout flares 67 solifenacin 67 daytime drowsiness 67 hypoglycaemic episodes 67 hypersomnia 67 TEAEs 67 incontinence episodes 67 oxycodone CR 66 hot flashes 66 depressive symptom 66 nocturnal awakenings 66 nighttime heartburn 66 menopausal symptom 66 hot flushes 65 daytime alertness 65 hypoglycemic events 65 somatic symptoms 65 pregabalin 65 SRBD 65 premenstrual symptoms 65 extrapyramidal symptoms 65 hypoglycemic episodes 64 tapentadol ER 64 premenstrual syndrome PMS 64 menstrual pain 64 depressive episodes 64 atopic eczema 64 subclinical hypothyroidism 64 severe exacerbations 64 parkinsonian symptoms 64 fluoxetine Prozac 64 bothersome symptom 64 ropinirole 64 excessive sleepiness 64 generalized anxiety disorder GAD 64 frequent awakenings 63 breast tenderness 63 depressive symptomatology 63 non aspirin NSAIDs 63 chronic insomnia 63 oxygen desaturation 63 CPAP adherence 63 amenorrhea 63 somnolence sleepiness 63 LUTS 63 migraineurs 63 dyspareunia 63 orthostatic hypotension 63 transient insomnia 62 salivary cortisol 62 pyridostigmine 62 EDSS scores 62 tegaserod 62 analgesic medications 62 neuropsychiatric symptoms 62 menopausal symptoms 62 COPD exacerbations 62 prolactin levels 62 PLMS 62 ALT flares 62 musculoskeletal pain 62 hay fever symptoms 62 Restless Legs Syndrome RLS 62 systemic corticosteroid 62 Heavy menstrual bleeding 62 Sleep disturbances 62 habitual snoring 62 asthma exacerbation 62 APTIVUS r 62 acromegalic patients 62 tolterodine 62 habitual snorers 62 EFFEXOR XR 62 MIRAPEX 62 sedating antihistamine 62 apneas 61 venlafaxine Effexor 61 tolterodine ER 61 Chronic insomnia 61 severe hypoglycaemia 61 asthma exacerbations 61 nasal obstruction 61 urinary tract symptoms 61 menstrual bleeding 61 MMSE scores 61 GERD 61 AGILECT R 61 nasal symptoms 61 bosentan 61 timepoints 61 arthralgias 61 adjunctive placebo 61 prednisone prednisolone 61 irritable bowel syndrome IBS 61 Overactive bladder 61 ramelteon 61 EXJADE 61 apnea hypopnea 61 generalized tonic clonic seizures 61 adrenal function 61 salivary flow 61 severe hypoglycemia 61 laboratory abnormalities 61 rhinoconjunctivitis 61 receiving golimumab 61 irregular menstrual cycles 61 OSAHS 61 sleep disturbances 61 Obstructive sleep apnea 61 anticholinergics 61 tolvaptan 61 recurrent VTE 61 akathisia 61 leucopenia 61 HAM D# 61 HbA1c levels 61 RLS sufferers 61 dysmenorrhoea 61 Depressive symptoms 61 eszopiclone 61 antidepressant therapy 61 anticholinergic drugs 61 nocturnal hypoglycemia 61 perimenopausal women 61 prodromal symptoms 61 anal incontinence 61 urinary retention 61 DETROL LA 61 Exacerbations 61 comorbid conditions 61 apnea hypopnea index 61 COPD exacerbation 60 constipation nausea 60 neurodevelopmental outcome 60 HPA axis suppression 60 diabetic neuropathic pain 60 quetiapine 60 Serious adverse reactions 60 virologic response 60 recurrent venous thromboembolism 60 nausea constipation 60 hypokalemia 60 transaminase elevations 60 Major Depressive Disorder 60 aripiprazole 60 colorectal adenomas 60 polycystic ovary syndrome PCOS 60 quetiapine XR 60 IELT 60 antihypertensive medications 60 nasal allergies 60 treatment emergent AEs 60 arousals 60 HRQL 60 baseline HbA1c 60 adalimumab 60 neuroleptics 60 cortisol secretion 60 blood Phe levels 60 hyperprolactinemia 60 Anxiety disorders 60 Fiorinal 60 serum uric acid 60 oxcarbazepine 60 Withdrawal symptoms 60 diarrhea nausea fatigue 60 insulin detemir 60 airflow obstruction 60 levodopa therapy 60 INVEGA R 60 Migraine headaches 60 PASI scores 60 VIIBRYD 60 dysfunctional voiding 60 REYATAZ r arm 60 Generalized anxiety disorder 60 Nocturia 60 Pramipexole 60 moderate renal impairment 60 hypopneas 60 artery calcification 60 overactive bladder OAB 60 intravenous bisphosphonates 60 insomnia 60 dyskinesia 60 neurocognitive deficits 60 Restless Legs Syndrome 60 adenotonsillectomy 60 lamotrigine 60 oral naltrexone 60 symptom flare ups 60 tranylcypromine 60 disordered breathing 60 abrupt discontinuation 60 uncontrolled asthma 60 paresthesias 60 acute gout flares 60 exacerbations 60 urge incontinence 60 valproate 60 desvenlafaxine succinate 60 INVEGA 60 spontaneous bowel movements 60 virological response 59 postoperative AF 59 KAPIDEX 59 detrusor overactivity 59 hyperkalemia 59 gastro esophageal reflux 59 extrapyramidal symptoms EPS 59 abdominal pain abdominal discomfort 59 psychotic symptoms 59 LYSTEDA 59 INVEGA ® 59 knee osteoarthritis OA 59 Hot flushes 59 erectile difficulties 59 systolic BP 59 antiepileptic drugs AEDs 59 parasomnias 59 clinically meaningful improvements 59 RLAI 59 elevated ALT 59 headache nausea fatigue 59 attention-deficit/hyperactivity disorder ADHD 59 febrile seizure 59 psychiatric comorbidities 59 FROVA 59 claudication 59 etanercept 59 perimenopausal symptoms 59 dyspnea 59 urinary leakage 59 lopinavir r arm 59 citalopram 59 serologically active patients 59 Irritable Bowel Syndrome IBS 59 serum IGF 59 hypercalcemia 59 stimulant medications 59 adrenal insufficiency 59 Vaginal dryness 59 perimenopause 59 PGTC seizures 59 corticosteroid therapy 59 ZOMIG Nasal Spray 59 ibandronate 59 dysmenorrhea 59 glucocorticoid therapy 59 antenatal depression 59 neurologic symptoms 59 enuresis 59 myalgias 59 nocturnal hypoglycaemia 59 #mg dose [001] 59 asthmatic symptoms 59 vaginal atrophy 59 salmeterol fluticasone 59 venlafaxine XR 59 acetabular dysplasia 59 aminotransferase elevations greater 59 efalizumab 59 extrapyramidal disorder 59 HbA 1c levels 59 events AEs 59 untreated sleep apnea 59 clomipramine 59 Hypocalcemia 59 somnolence dizziness 59 nortriptyline 59 montelukast 59 sleep disordered breathing 59 amenorrhoea 59 painful menstruation 59 proliferative diabetic retinopathy 59 serum estradiol 59 fluticasone salmeterol 59 QTc interval 59 febrile seizures 59 spontaneous erections 59 beta blocker therapy 59 autonomic dysfunction 59 ATACAND 59 aminotransferases 59 manic hypomanic 59 abnormal ejaculation 59 ACTEMRA TM 59 MIRAPEX ER 59 bladder contractions 59 hyperalgesia 59 BYSTOLIC 59 cyclic HMB 59 hypomagnesemia 59 loop diuretics 59 octreotide LAR 59 thyrotropin levels 59 frequent heartburn 59 psychiatric comorbidity 59 hyperreflexia 59 steroid dexamethasone 59 Abdominal pain 59 antihypertensive therapy 58 Antidepressant medications 58 #mg doses [002] 58 inhaled budesonide 58 episodic migraine 58 T2DM 58 intractable hiccups 58 nighttime urination 58 timepoint 58 tiotropium 58 hyperphenylalaninemia HPA due 58 RLS 58 onset seizures 58 receiving VELCADE 58 upper gastrointestinal bleeding 58 dysuria 58 MADRS score 58 corticosteroid dose 58 functional dyspepsia 58 treprostinil 58 paroxetine Paxil 58 dysthymia 58 severe hypoglycemic 58 dopaminergic therapy 58 virological failure 58 melatonin supplements 58 syncopal 58 dyskinesias 58 annualized relapse 58 daytime naps 58 nasal allergy symptoms 58 PREZISTA r 58 magnesium intake 58 treatment emergent adverse 58 depressive episode 58 tamsulosin 58 #mg/day [001] 58 ziprasidone 58 vertebral fracture 58 fasting glucose levels 58 rotigotine 58 salmeterol HFA MDI 58 lacosamide 58 EDARBI 58 β blockers 58 mg BID 58 serum sodium 58 serum phosphate levels 58 divalproex sodium 58 juvenile idiopathic arthritis 58 MCyR 58 emotional lability 58 hypovolemia 58 postoperative complications 58 knee osteoarthritis 58 comorbid ADHD 58 urinary incontinence 58 URTI 58 endometrial hyperplasia 58 non menstrual pelvic 58 serum sodium levels 58 DPNP 58 euthymic 58 elevated creatinine 58 intractable epilepsy 58 adjunctive ABILIFY 58 serum vitamin D 58 urate levels 58 subtrochanteric 58 Migraine sufferers 58 nondepressed 58 Adverse events 58 myelosuppression 58 oral olanzapine 58 urinary incontinence UI 58 HIV HCV coinfected 58 hypovitaminosis D 58 paroxysmal AF 58 metabolic acidosis 58 mg dose 58 Index CDAI 58 nocturnal enuresis 58 Scale EDSS score 58 clinically meaningful improvement 58 nausea fatigue 58 IR prednisone 58 postoperative complication 58 alexithymia 58 ARICEPT 58 nonvertebral fractures 58 recurrent miscarriage 58 sulfasalazine 58 dosage regimens 58 rimonabant #mg 58 serum urate 58 HRQOL 58 HbA1C levels 58 premenstrual syndrome 58 vitamin D inadequacy 58 serum calcium levels 58 coronary calcification 58 obstructive apnea 58 chronic prostatitis 58 TNF antagonist 58 apneic episodes 58 nonadherence 58 Premature ejaculation 58 comorbid depression 58 recurrent abdominal pain 58 AZILECT 58 hematologic toxicity 58 potassium sparing diuretics 58 dizziness nausea diarrhea 58 ruboxistaurin 58 hypophosphatemia 58 postoperative mortality 58 Excessive daytime sleepiness 58 cytogenetic response 58 hematological toxicity 58 Major depressive disorder 58 Drowsiness 58 serum cortisol 58 citalopram Celexa 58 migraine sufferers 58 AVODART 58 chronic heartburn 58 ziconotide 58 Daytime drowsiness 58 Thrombocytopenia 58 lipid parameters 58 antioxidant supplementation 58 torsade de pointes 58 NPH insulin 58 COPAXONE R 58 PONV 58 thromboembolic events 57 hypercholesterolaemia 57 menorrhagia 57 neurodevelopmental impairment 57 Migraines 57 severe asthma exacerbations 57 leukopenia 57 #mg dose [003] 57 receiving XGEVA 57 serum phosphate 57 COREG 57 GERD symptom 57 hemoglobin A1c levels 57 PREZISTA r arm 57 racemic albuterol 57 cilostazol 57 gastrointestinal symptoms 57 vesicoureteral reflux 57 renal impairment 57 oral corticosteroid 57 sertraline Zoloft 57 Keppra R 57 achieved ACR# 57 EDSS score 57 decrements 57 hypoglycaemia 57 depressive disorders 57 T1DM 57 CVD mortality 57 subsyndromal 57 polyuria 57 antihypertensive medication 57 UPDRS scores 57 CMV infection 57 intermittent claudication 57 azoospermia 57 hallucinations dyskinesia 57 teriflunomide 57 alpha blockers 57 hypoglycemia 57 levetiracetam 57 serum creatinine levels 57 nausea photophobia 57 triptans 57 atypical antipsychotic medications 57 carotid stenosis 57 postprandial glucose 57 overactive bladders 57 valacyclovir 57 neurocognitive functioning 57 depression irritability 57 NIH CPSI 57 chronic migraine 57 overt hypothyroidism 57 cough wheezing 57 neurologic dysfunction 57 severe obstructive sleep 57 Endothelial function 57 tricyclic antidepressants 57 myopathy rhabdomyolysis 57 REYATAZ ritonavir 57 postherpetic neuralgia 57 nausea vomiting headache 57 night wakings 57 A1C levels 57 CLBP 57 ICD shocks 57 prescribed opioids 57 hemoglobin A1c HbA1c 57 premenopause 57 discontinuations due 57 daytime somnolence 57 induce orthostatic hypotension 57 HeFH 57 left ventricular dysfunction 57 vulvodynia 57 thiazide diuretics 57 intermittent hypoxia 57 ropivacaine 57 prodrome 57 calcium supplementation 57 urge urinary incontinence 57 obstructive sleep apnea OSA 57 urinary oxalate 57 hyperammonemia 57 aspirin NSAIDs 57 Generalized Anxiety Disorder 57 haloperidol Haldol 57 paresthesia 57 Irritable bowel syndrome 57 Chronic ITP 57 pentoxifylline 57 dyslipidaemia 57 esomeprazole 57 bipolar depression 57 haemorrhagic stroke 57 laxation 57 heavy menstrual bleeding 57 menstrual irregularities 57 irritability drowsiness restless 57 GnRH agonists 57 tic disorder 57 chronic musculoskeletal 57 radicular pain 57 menstrual migraines 57 nifedipine 57 Cluster headaches 57 androgen deficiency 57 gouty arthritis 57 generalized seizures 57 CONCERTA 57 syncopal episodes 57 IBS sufferers 57 urinary cortisol 57 Psoriasis Area 57 nulliparous women 57 severe psoriasis 57 serum testosterone 57 venous thrombosis 57 inactive placebo 57 juvenile idiopathic arthritis JIA 57 Sleep disordered breathing 57 euthymic patients 57 HBeAg positive patients 57 AGILECT ® 57 affective disorder 57 dosing frequency 57 intracranial hypertension 57 lichen planus 57 NIHSS score 57 postoperative nausea 57 adrenal suppression 57 vaginal progesterone gel 57 reflux disease 57 hours postdose 57 certolizumab 57 A1c levels 57 myalgia arthralgia 57 PMDD 57 fibromyalgia 57 8mg/kg 57 tiotropium bromide 57 hypocalcemia 57 allergy symptoms 57 menstrual migraine 57 mixed hyperlipidemia 57 PREMPRO 57 QTc prolongation 57 neurocognitive function 57 sleepiness 57 dietary calcium intake 57 prolonged QT interval 57 selegiline 57 Chronic pelvic 57 fluoxetine 57 hyperactivity impulsivity 57 CANCIDAS 57 Lamictal XR 57 Treatment emergent adverse 57 testosterone supplementation 57 dentinal hypersensitivity 57 transaminase levels 57 gastroesophageal reflux 57 uncontrolled seizures 57 partial onset seizures 57 QoL 57 carotid IMT 57 dyspnoea 57 zolmitriptan 57 plasma folate 57 tryptophan depletion 57 syncopal episode 57 anticonvulsant medications 57 MMSE score 57 premenstrual dysphoric disorder 57 hip BMD 57 knee OA 57 Adalimumab 57 bacterial vaginosis 57 placebo p = 57 arterial thromboembolic events 57 cholinesterase inhibitor 57 hyperglycaemia 57 VIRAMUNE XR 57 symptoms 57 Hypoactive Sexual Desire Disorder 57 somnolence sedation 57 mg Proellex 57 MBCT 56 morphometric vertebral fractures 56 ROZEREM 56 Hypotension 56 Triptan 56 sleep apneas 56 ULTRAM ER 56 serum potassium 56 Expanded Disability Status 56 primary hypercholesterolemia 56 abdominal pain flatulence 56 atrophic gastritis 56 quinidine 56 IBS C 56 NYHA class 56 FAMPYRA 56 diabetic gastroparesis 56 preterm deliveries 56 allodynia 56 parkinsonism 56 angina chest 56 adrenal exhaustion 56 CONCERTA ® 56 adverse reactions incidence 56 MULTAQ 56 mcg QD 56 relapsing MS 56 HDRS 56 MOTN awakenings 56 Peripheral edema 56 mood disorders 56 postsurgical pain 56 urate lowering therapy 56 alemtuzumab treated 56 tipranavir r 56 glucose tolerance test 56 irregular menses 56 INVEGA ® SUSTENNA TM 56 nonfatal MI 56 TMP SMX 56 #mg dose [002] 56 nonvertebral fracture 56 deep venous thromboses 56 mild renal insufficiency 56 gastric pH 56 Postnatal depression 56 diarrhea flatulence 56 NAbs 56 PRISTIQ 56 bronchoconstriction 56 post herpetic neuralgia PHN 56 androgen excess 56 tonic clonic seizures 56 proteinuria 56 status epilepticus 56 ALT elevations 56 nadroparin 56 coadministration 56 Calcium intake 56 asymptomatic PAD 56 NATRECOR R 56 headache abdominal pain 56 retinal thickness 56 aldosterone antagonists 56 candesartan 56 recurrent tonsillitis 56 osteoporotic fracture 56 diarrhea predominant IBS 56 postnatally 56 lactic acidosis 56 SSRI SNRI 56 esophagitis 56 molindone 56 glycated hemoglobin levels 56 pruritis 56 urinary tract symptoms LUTS 56 virologic failure 56 Hepatotoxicity 56 macroalbuminuria 56 L dopa 56 neurodevelopmental disability 56 lumbar spine BMD 56 severe menopausal symptoms 56 Perforomist Inhalation Solution 56 clinically meaningful reductions 56 insomnia sufferers 56 albuminuria 56 probiotic supplementation 56 pelvic pain 56 comorbid disorders 56 MetS 56 non hematological toxicities 56 dose colchicine 56 hypofractionated radiation 56 psychological distress 56 venous thromboembolic events 56 overactive bladder OAB symptoms 56 postoperative delirium 56 LEXIVA 56 SGRQ 56 antiemetics 56 tardive dyskinesia TD 56 PLMs 56 attain statistical significance 56 CIMZIA ™ 56 unipolar depression 56 alanine aminotransferase ALT 56 generalized epilepsy 56 primary generalized tonic 56 CIPN 56 ARB telmisartan 56 neurocognitive impairment 56 urine leakage 56 anticonvulsants 56 plus methotrexate 56 neurological abnormalities 56 untreated OSA 56 mood swings irritability 56 Spinal manipulation 56 androgen deprivation 56 ginkgo biloba extract 56 NATRECOR ® 56 SAPHRIS 56 hydroxychloroquine 56 upper airway obstruction 56 neurologic outcomes 56 gout flare 56 interstitial cystitis 56 Mood disorders 56 psychiatric morbidity 56 methotrexate monotherapy 56 neurologic complications 56 subclinical hyperthyroidism 56 anovulation 56 Ejection Fraction 56 mesalamine granules 56 interpersonal psychotherapy 56 comorbid psychiatric 56 definite stent thrombosis 56 #OHD levels 56 MS relapses 56 somatic complaints 56 syndrome RLS 56 QT intervals 56 Tardive dyskinesia 56 Chronic constipation 56 vertebral fractures 56 excessive daytime sleepiness 56 migraines 56 serum potassium levels 56 systolic hypertension 56 recurrent wheezing 56 oral prednisolone 56 4mg/kg 56 acamprosate 56 tibolone 56 gastro oesophageal reflux 56 Crohn Disease Activity 56 HAM D# scores 56 ADHF 56 thrombotic events 56 virologic breakthrough 56 psychosocial variables 56 nasal congestion sore throat 56 comorbidities 56 depressive relapse 56 protein excretion 56 aromatase inhibitor therapy 56 hsCRP levels 56 gemifloxacin 56 corrected QT interval 56 headache nasopharyngitis 56 rufinamide 56 HSDD 56 macrovascular events 56 generalized edema 56 hypoxemia 56 chronic neurological disorder 56 cognitive impairment 56 airflow limitation 56 intravitreal injections 56 inhaled fluticasone 56 Obstructive sleep apnea OSA 56 teriparatide 56 SGPT 56 gastrointestinal toxicity 56 chorioamnionitis 56 alteplase 56 renal toxicity 56 conjunctival hyperemia 56 abdominal distension 56 WOMAC pain 56 HRQoL 56 polycystic ovary syndrome 56 adiponectin levels 56 affective psychoses 56 fibromyalgia syndrome 56 photosensitivity rash 56 artery stenosis 56 post thrombotic syndrome 56 neurodevelopmental outcomes 56 conjugated equine estrogen 56 aplindore 56 serum folate concentrations 56 events TEAEs 56 FOLPI regimen 56 Infusion Reactions Severe 56 hyperemesis 56 anakinra 56 intermittent dosing 56 rhinitis 56 gastric acidity 56 Ulcerative colitis 56 CP CPPS 56 postprocedure 56 cryptorchidism 56 intravenous diuretics 56 menopausal hot flushes 56 abdominal bloating 56 Wisconsin Sleep Cohort 56 RISPERDAL ® 56 serum urate levels 56 aminotransferase levels 56 serum folate 56 PSADT 56 nausea somnolence 56 ARCALYST ® 56 Hoarseness 56 cerebral infarction 56 variceal bleeding 56 atopic 56 budesonide formoterol 56 intensive statin therapy 56 placebo 56 digestive discomfort 56 Hypoglycemia 56 febrile neutropenia 56 Vagifem 56 psychosocial functioning 56 INVEGA ™ 56 oral corticosteroids 56 spontaneous preterm delivery 56 glargine 56 painful urination 56 moderate aerobic exercise 56 menses 56 Thal Dex 56 divalproex 56 abdominal swelling 56 arterial stiffness 55 ACTOplus met 55 amisulpride 55 alfuzosin 55 L DOPA 55 amoxicillin clavulanate 55 delayed CINV 55 tacrolimus ointment 55 conventional antipsychotics 55 CLA supplementation 55 placebo controlled clinical trials 55 renal dysfunction 55 chronic rhinosinusitis 55 Secondary endpoints 55 baclofen 55 caffeine intake 55 Duloxetine 55 H2 receptor antagonists 55 blepharospasm 55 systolic dysfunction 55 reinfarction 55 FOLFOX4 55 hypomanic symptoms 55 PANSS scores 55 TLUS 55 epigastric pain 55 Toviaz 55 serotonin reuptake inhibitors 55 acute mania 55 inflammatory lesions 55 fragility fracture 55 light headedness dizziness 55 recurrent infections 55 hyperarousal 55 posttreatment 55 renal insufficiency 55 Irritability 55 bronchodilation 55 fasting plasma glucose 55 antiepileptic drugs 55 obstetric complications 55 atrioventricular block 55 antihypertensive drugs 55 ethosuximide 55 aldosterone antagonist 55 vertigo dizziness 55 opioid analgesia 55 drowsiness dizziness 55 BMI z 55 BoNTA 55 xerostomia 55 dextromethorphan DM 55 Ankylosing spondylitis 55 rheumatic disease 55 placebo p 55 Bruxism 55 fecal incontinence 55 lipid levels 55 perennial allergic rhinitis 55 YMRS 55 Sleepiness 55 pyloric stenosis 55 folate intake 55 Tasimelteon 55 Erythropoietic therapies may 55 primary axillary hyperhidrosis 55 CDI recurrence 55 bezafibrate 55 onset atrial fibrillation 55 symptomatic VTE 55 Victoza R 55 spironolactone 55 chronicity 55 SUSTENNA TM 55 NUVIGIL 55 acarbose 55 SCIg 55 antimuscarinic 55 dapagliflozin plus 55 FASLODEX 55 acid regurgitation 55 thyroid hormone levels 55 PREZISTA ritonavir 55 wakings 55 corticosterone levels 55 6MWD 55 Adverse reactions 55 osteoarthritis rheumatoid arthritis 55 tardive dyskinesia 55 nasal symptom 55 antidepressant efficacy 55 VaD 55 fructose diet 55 antiarrhythmic drugs 55 Cognitive impairment 55 coronary artery calcification 55 diastolic hypertension 55 Overactive Bladder 55 hypoperfusion 55 IUGR 55 amitriptyline 55 peripheral sensory neuropathy 55 Sinemet 55 Chronic cough 55 QT interval prolongation 55 Irritable Bowel Syndrome 55 Sexual dysfunction 55 albumin excretion 55 STN stimulation 55 typical antipsychotics